This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Abnova
product type :
antibody
product name :
HIST1H3A (phospho S10) polyclonal antibody
catalog :
PAB29616
quantity :
100 uL
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human, mouse
application :
western blot, immunocytochemistry, immunohistochemistry - paraffin section
product information
catalog id :
PAB29616
product name :
HIST1H3A (phospho S10) polyclonal antibody
product description :
Rabbit polyclonal antibody raised against synthetic phosphopeptide of human HIST1H3A.
gene name :
HIST1H3A
gene alias :
H3/A H3FA
gene description :
histone cluster 1, H3a
immunogen :
A synthetic phosphopeptide (conjugated with KLH) corresponding to residues surrounding S10 of human HIST1H3A.
protein accession :
P68431
form :
Liquid
recommend dilutions :
Immunofluorescence (1:100-1:200). Immunohistochemistry (1:50-1:100). Western Blot (1:500-1:1000). The optimal working dilution should be determined by the end user.
storage buffer :
In PBS (without Mg 2+ and Ca 2+ ), 150 mM NaCl, pH 7.4 (50% glycerol, 0.02% sodium azide)
storage instruction :
Store at 4 C. For long term storage store at -20 C. Aliquot to avoid repeated freezing and thawing.
note :
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
type clonality :
Antibody
raised in host species :
Rabbit
antigen species target species :
Human
specificity :
HIST1H3A (phospho S10) polyclonal antibody detects endogenous level of HIST1H3A only when phosphorylated at serine 10.
species reactivity cross reactivity :
Human,Mouse,Rabbit
application key :
WB-Ce,IHC-P,IF
size :
100 uL
autodate :
2015-10-30
updatetime :
2015-11-02 10:20:45
company information
Abnova
9th Fl., No.108, Jhouzih St.
Neihu District. Taipei City
114 Taiwan
Neihu District. Taipei City
114 Taiwan
sales@abnova.com
https://www.abnova.com877-853-6098
questions and comments